Tuula Pirttilä

发表

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Katharina Buerger, Frank Padberg, Harald Hampel, 2002, Archives of neurology.

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Ludwig Kappos, Leena Peltonen, Pentti Tienari, 2010, American journal of human genetics.

Synergistic effect of apolipoprotein E ϵ4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

Hilkka Soininen, Clive Ballard, Steven H Ferris, 2008, Pharmacogenetics and genomics.

Neurofilament ELISA validation.

Bernhard Hemmer, Gavin Giovannoni, Johannes Kornhuber, 2010, Journal of immunological methods.

CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy.

Hilkka Soininen, Corina Pennanen, H. Soininen, 2008, Journal of Alzheimer's disease : JAD.

Relationship between apoE genotype and CSF β-amyloid (1–42) and tau in patients with probable and definite Alzheimer’s disease

Hilkka Soininen, Irina Alafuzoff, H. Soininen, 2000, Neurobiology of Aging.

CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.

Hilkka Soininen, Susanna Tervo, Merja Hallikainen, 2007, Neurobiology of aging.

CSF Aβ42, Tau and phosphorylated Tau, APOE ɛ4 allele and MCI type in progressive MCI

Hilkka Soininen, Susanna Tervo, Merja Hallikainen, 2007, Neurobiology of Aging.

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

Sakari Savolainen, Kjell Någren, Ville Leinonen, 2008, Archives of neurology.

Potential cost-effectiveness of a family-based program in mild Alzheimer’s disease patients

Janne Martikainen, Hannu Valtonen, T. Pirttilä, 2004, The European Journal of Health Economics, formerly: HEPAC.

CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment

Hilkka Soininen, Merja Hallikainen, H. Soininen, 2005, Neurology.

Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

Tuula Pirttilä, Antero Salminen, George Anderson, 2012, Journal of Neuroinflammation.

A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease.

Aki Vehtari, Kimmo Kaski, Olli Gröhn, 2008, Biochemical and biophysical research communications.

Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients

Heikki Tanila, Irina Alafuzoff, H. Tanila, 2009, Neurobiology of Aging.